“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: ADAMTS13 deficiency in mice does not aggravate diet-induced liver steatosis

€3.03

SKU: product-article-19245 Category: General

Description
Reviews (0)

Description

ADAMTS13 deficiency in mice does not aggravate diet-induced liver steatosis

Reviews

There are no reviews yet.

Be the first to review “Article: ADAMTS13 deficiency in mice does not aggravate diet-induced liver steatosis”

You must be logged in to post a review.

Top

Article: ADAMTS13 deficiency in mice does not aggravate diet-induced liver steatosis

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Highlights in breast cancer

Article: Highlights in breast cancer

Article: Highlights in breast cancer